Pz peptidases A and B, from a thermophile Geobacillus collagenovorans MO-1, recognize collagenspecific tripeptide units (Gly-Pro-Xaa). They share similarities in function but extremely low identities in primary sequence with mammalian thimet oligopeptidase (TOP) and neurolysin. Three phosphine peptide inhibitors that selectively inhibit TOP and neurolysin on two bacterial Pz peptidases were investigated. They showed potent inhibition of both Pz peptidases in a range from 10 to 100 nM.
Collagen degradation and the related enzymes, which are factors in many biological and medical issues, are fascinating to biochemists, microbiologists, and medical researchers. 1) In the major degradation pathway of collagen by endogenous as well as exogenous systems, cleavage by collagen-specific proteases recognizing a collagen-specific sequence (Gly-Pro-X) is an essential action. A thermophilic collagen-degrading bacterium, Geobacillus collagenovorans MO-1, isolated in Kyoto, Japan, produces an extracellular and collagenolytic protease that can specifically bind with and digest collagen at multiple sites, but not at numerous repetitions of a collagen-specific tripeptide sequence (GlyPro-X). 2, 3) The resulting collagen-hydrolyzed fragments are further digested to smaller oligopeptides by two intracellular oligopeptidases that recognize collagenspecific tripeptide units. 1, 4) The two oligopeptidases responsible for the second digestion are called Pz peptidases A and B on account of the synthetic substrate, 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (Pz-PLGPR), containing the collagen-specific sequence. 4) On the other hand, an enzyme called thimet oligopeptidase (TOP), or endopeptidase 24-15 (E.C.
3.4.24.15), which hydrolyzes synthetic oligopeptide substrates at the same sites as those of bacterial Pz peptidases, is known to occur in mammalian cells. 5, 6) Although TOP was previously thought to be a collagenmetabolizing enzyme in mammalian cells, its main role is to extinguish the signaling action of short neuropeptides by metabolizing oligopeptides. 5) In addition, X-ray crystallography analysis of TOP was recently completed at 2.0 Å resolution by the molecular replacement method with data for neurolysin (or endopeptidase 24-16), a highly homologous neuropeptidase which shares more than 60% identity with TOP in the amino acid sequence. 7, 8) But TOP shares only 11 and 14% identity with Pz-peptidases A and B respectively, and there is only 22% identity between Pz-peptidases A and B.
4) The characteristic differences raised our interest in clarifying the real structures of these two Pz peptidases and the difference between TOP and neurolysin in terms of function and structure. Dive et al. have developed various phosphine peptide inhibitors that specifically inhibit TOP and neurolysin. 9, 10) For this study, three phosphine peptide inhibitors were given so that we could investigate how the two Pz peptidases behave against inhibitors of TOP and neurolysin prior to structure analysis by X-ray crystallography.
To purify Pz peptidase A overexpressed in E. coli BL21(DE3), the DNA fragment containing the Pz peptidase A gene was amplified with two primers (AF1, AGGGATCCATATGAAATTTTCTGAGTTTCGTTA; and AR1, CGCGGATCCTAATCAGGTCTACACCTC-CC) using a cloned DNA fragment containing the gene for Pz peptidase A as a template DNA by PCR. 4 ) PCR was preformed with KOD DNA polymerase (Toyobo, Osaka, Japan) for 30 cycles according to the manufacturer's specifications. Denaturation, annealing, and extension temperatures were 94 C for 15 s, 50 C for 30 s, and 68 C for 2 min respectively. The PCR-derived y To whom correspondence should be addressed. Tel/Fax: +81-75-703-5667; E-mail: kwatanab@kpu.ac.jp Abbreviations: Pz-PLGPR, 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg; TOP, thimet oligopeptidase; MCC-PLGPK, 7-methoxycoumarin-3-carboxylyl-Pro-Leu-Gly-Pro-D-Lys(2,4-dinitrophenyl); Z, benzyloxycarbonyl fragment was digested with NdeI and BamHI and then inserted into the NdeI-BamHI site of vector plasmid pET11a (Novagen, Madison, WI). The resulting plasmid, pETA-1, was used to transform E. coli BL21 (DE3). The recombinant Pz peptidase A was overexpressed in the transformant at 37
C by the addition of isopropyl--D-galactopyranoside (final concentration 1 mM) for 2 h after cell growth reached OD 660 to 0.5 in L broth (1% w/v peptone, 0.5% w/v yeast extract, 0.5% w/v NaCl, pH 7.2) containing 50 mg/ml ampicillin. Cells harvested from the culture (total 200 ml) were resuspended in 30 ml of 50 mM Tri-HCl, pH 7.5 (buffer I), and disintegrated by sonication. Cell-free extract obtained by centrifugation at 12;000 Â g for 30 min was kept at 60 C for 30 min. The heat-denatured sediment was excluded and the resulting supernatant was applied to a DEAE-cellulose column (2:0 Â 12 cm), equilibrated with buffer I, and then eluted with a linear gradient from 0 to 0.5 M NaCl in buffer I (total 250 ml). The active fractions (1.5 ml each) were pooled and concentrated to 3 ml by ultrafiltration through an Amicon PM-10 membrane (Millipore, Bedford, MA). The concentrate was put onto a Sephadex G-200 column (1:8 Â 95 cm) equilibrated with buffer I. Active fractions (1.5 ml each) were pooled and concentrated by ultrafiltration.
To purify Pz peptidase B overexpressed in E. coli BL21 (DE3) under the control of its intact promoter, DNA fragment (BamHI-PstI) containing the Pz peptidase B gene was inserted into the same restriction site of vector plasmid pUC119. 4, 11) E. coli cells transformed with the resulting hybrid plasmid (pOPB-1) were incubated at 37 C in L broth (total 800 ml) for 10 h. The cells were disrupted by sonication in 100 ml of buffer I, and the cell-free extract was obtained as described for Pz peptidase A. Then heat treatment and centrifugation processes were carried out as described above but at 65 C. The resulting supernatant was applied and eluted to a DEAE-cellulose column (2:0 Â 11:1 cm) and then a Sephadex G-200 column (1:9 Â 95 cm), as described for Pz-peptidase A. The active fractions from the latter column were pooled, concentrated, and then put onto a hydroxyapatite column (1:9 Â 3:9 cm) equilibrated with 10 mM potassium phosphate buffer (pH 7.5) after they were dialyzed against the same buffer. They were eluted with a linear gradient of 10 to 300 mM potassium phosphate buffer (total 100 ml), pooled, and concentrated by ultrafiltration. A standard assay of Pz peptidase activities for purification was performed using Pz-PLGPR (Bachem, Bubendorf, Switzerland), as previously described. 4, 12) One unit of enzyme activity using the substrate defined one mmol Pz-PLGPR hydrolyzed in 1 min.
Pz peptidases A and B were smoothly overexpressed in E. coli BL21 (DE3) harboring recombinant plasmids pETA-1 and pOPB-1 respectively, without any inhibitory effect on cell growth. Most fractions of recombinant proteins of the two Pz peptidases were soluble in the cell-free extract. The two Pz peptidases were purified to homogeneity with the purity and yield shown in Fig. 1 and Table 1 . The specific activities of Pz peptidases A and B for the final samples showed 30.4 and 19.5 U/mg-protein respectively for Pz-PLGPR as a substrate. Those values are larger than those (24.7 and 2.32 U/mg-protein, respectively) from the original strains in the previous report. 4) In particular, recombinant Pz peptidase B was found to be 8-fold more active than that from the original strain, mainly due to rapid and efficient purification of the recombinant enzyme without any damage to enzyme function. In addition, the specific activities of the final sample of the two The specific activities were determined using Pz-PLGPR as a substrate.
recombinant Pz peptidases (Table 1) indicate that there was a smaller difference in enzyme function for the substrate than reported previously.
4)
The kinetic parameters and K i values of phosphine peptides for the two Pz peptidases were investigated by the method described in a previous report, 13) by the use of a fluorescence substrate, 7-methoxycoumarin-3-carboxylyl-Pro-Leu-Gly-Pro-D-Lys(2,4-dinitrophenyl) (MCC-PLGPK; Merck, Frankfurt, Germany). This is because it was impossible to determine those parameters by the use of Pz-PLGPR due to the non-negligible effect of the organic solvent (dimethylsulfoxide) solubilizing the substrate on activity in a higher range of substrate concentration. A typical reaction mixture contained 2.5 mM substrate and 50 mM HEPES-NaOH (pH 7.6 for Pz peptidase A and pH 8.4 for Pz peptidase B) (buffer II) at a total volume of 2 ml in a cuvette. Continuous assay was done at 60 C by monitoring the hydrolysis of the fluorescent substrate with a fluorescence spectrophotometer (Shimadzu RF5300PC, Kyoto, Japan), with the excitation and emission wavelengths set at 345 and 405 nm respectively.
Basic kinetic parameters were determined from a Lineweaver-Burk plot. The K m and V max values for Pz peptidases A and B were 8.19 mM and 3.73 mmol/min/ mg-protein, and 6.45 mM and 4.26 mmol/min/mg-protein, respectively. This result also suggests that there was no remarkable difference between the two Pz peptidases in enzyme function.
To determine the K i values of the three phosphine peptides, Pz peptidases (final concentration 3.7 nM) were preincubated with various concentrations of phosphine peptides,
, and Gly-Pro-Phe-(PO 2 CH 2 )-Gly-Pro-Nle (compound 2), the kind gift of Dr. V. Dive, 9, 10) at 0 C in buffer I for 24 h. The mixture was then transferred to a cuvette, and MCC-PLGPK substrate (final concentration 4 to 20 mM) was added soon after the temperature in the fluorescence spectrophotometer reached 60 C. Inhibition of enzyme activities was monitored, and K i values were determined from their Dixon plots. The inhibitory potency and selectivity of the three phosphinic peptide inhibitors, which are specific to thimet oligopeptidase and neurolysin, toward two Pz peptidases were examined by the use of MCC-PLGPK. Pz peptidase A showed similar sensitivities (around 90 nM) toward the three phosphine inhibitors, indicating that the three phosphine peptides showed common potencies but no selectivity toward the enzyme (Table 2 ). In contrast, for Pz peptidase B, the strongest inhibition was observed with the neurolysinspecific inhibitor compound 2 (19.2 nM); this was twice as strong as the TOP-specific inhibitors, compounds 1 (43.9 nM) and 1 0 (37.8 nM). The inhibition mechanisms of the three inhibitors are most likely competitive, judging from the substrate-homologous structure of the inhibitors and the inhibitory patterns which were dependent on the concentration (data not shown). The inhibition of TOP and neurolysin by compounds 1 and 2 was by far more potent and selective than that of the two Pz peptidases, as reported by Jiracek et al. (Table 2) . 10) It is noteworthy that compound 2 contained in part a collagen-specific tripeptide sequence, Gly-Pro-X, whereas neither compound 1 nor compound 1 0 contained such a specific amino acid sequence. This finding suggests that Pz peptidase B recognizes the collagenspecific sequence Gly and Pro at the P1 0 and P2 0 positions more rigidly than Pz peptidase A; therefore, Pz peptidase A more likely shows a wider substrate specificity than does Pz peptidase B. No difference in the substrate specificity of the two Pz-peptidases was noted, 4) but it is interesting that compound 2 is two orders of magnitude more potent on neurolysin than on TOP even though neurolysin is not a collagen-metabolizing enzyme. In addition, judging from the results obtained with compounds 1 and 1 0 , the amino acid at the P3 0 position has an insignificant effect on the potency of the inihibitors. Furthermore, the role in selectivity played by the two inhibitors in the P1 0 position was not observed in the two Pz peptidases. 10) Although TOP and neurolysin commonly have a deep channel running the entire length of the molecule as an active site corresponding to rather high identity, 7, 8) the structure of Pz The data are derived from the previous reports. 9, 10) c N.D., no data.
peptidases at the active site is probably different from that of the characteristic channel. Thus far, in spite of extensive research, we have failed to find specific inhibitors showing keen inhibitory potency with K i values as small as 10-100 nM. In that sense, it is very significant to find potent phosphine peptide inhibitors that satisfy the requirements of this study. To our knowledge, this study is the first to report potent inhibitors of bacterila Pz peptidases and to compare their potencies with the sensitivities of TOP and neurolysin. Currently, we are conducting X-ray crystallographic analyses of two Pz peptidases using the inhibitors, and we have succeeded in obtaining co-crystals. It is noteworthy that there is no report describing the real structures of TOP and neurolysin based on X-ray crystallographic analysis using the complex with substrate derivatives or inhibitors. Hence, X-ray crystallographic analysis of two Pz peptidases is the next step in our research.
